Intellectual Property India Publishes Patent Application for 'Combinations Of Lsd1 Inhibitors And Menin Inhibitors For Treating Cancer' Filed by Oryzon Genomics, S. A.

MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202547058822 A) filed by Oryzon Genomics, S. A., Madrid, on June 19, for 'combinations of lsd1 inhibitors and menin inhibitors for treating cancer.'

Inventor(s) include Sacilotto, Natalia; and Soliva Soliva, Robert.

The application for the patent was published on June 27, under issue no. 26/2025.

According to the abstract released by the Intellectual Property India: "The instant invention relates to combinations of an LSD1 inhibitor (or a pharmaceutically acceptable salt thereof) and a Menin inhibitor (or a pharmaceutically acceptable salt thereof). The combinations are particularly useful for treating cancer, including hematological cancers, such a...